医学
组织学
威尔姆斯瘤
化疗
阶段(地层学)
内科学
肿瘤科
放射治疗
外科
生物
古生物学
作者
Frank M. Balis,Daniel M. Green,Amy J. Armstrong,Jamie M. Aye,Daniel J. Benedetti,Brandon Brown,Erin G. Brown,Shelly Cook,Ami V. Desai,Jasreman Dhillon,Douglas Fair,Daniel M. Geynisman,Susan M. Hiniker,Kelly K. Horst,Rama Jasty‐Rao,Marissa Just,Kathleen Kieran,Chi Lin,Iain MacEwan,Julián A. Martínez-Agosto
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2025-08-01
卷期号:23 (8): 319-342
被引量:3
标识
DOI:10.6004/jnccn.2025.0037
摘要
The NCCN Clinical Practice Guidelines (NCCN Guidelines) for Wilms Tumor (WT; nephroblastoma) cover strategies for the screening, diagnosis, and treatment of WT, which is the most frequent primary kidney tumor in children. WT can generally be separated into 2 histology types: favorable histology WT and anaplastic WT. Five-year survival is high for children with favorable histology WT who receive appropriate treatment; however, survival rates are much lower for patients who present with higher stage diffuse anaplastic WT. Treatment of WT can range from surgery alone to surgery plus intensive chemotherapy and radiation depending on whether the tumor is unilateral or bilateral, histology, and local stage. The goal of therapy is to maximize cure while minimizing long-term toxicities. The content featured in this issue covers the NCCN panel's recommendations for overall management of both favorable histology WT and anaplastic WT.
科研通智能强力驱动
Strongly Powered by AbleSci AI